DORNASE ALFA and COUGH

Overview

COUGH is the #5 most commonly reported adverse reaction for DORNASE ALFA, manufactured by Genentech, Inc.. There are 980 FDA adverse event reports linking DORNASE ALFA to COUGH. This represents approximately 3.3% of all 29,815 adverse event reports for this drug.

Patients taking DORNASE ALFA who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is moderately reported among DORNASE ALFA users, representing a notable but not dominant share of adverse events.

Other Side Effects of DORNASE ALFA

In addition to cough, the following adverse reactions have been reported for DORNASE ALFA:

• INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS — 2,282 reports
• CYSTIC FIBROSIS — 1,727 reports
• HOSPITALISATION — 1,289 reports
• PNEUMONIA — 1,269 reports
• OFF LABEL USE — 934 reports
• INFECTION — 922 reports
• NO ADVERSE EVENT — 919 reports
• DYSPNOEA — 898 reports
• CONDITION AGGRAVATED — 601 reports
• HEADACHE — 536 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does DORNASE ALFA cause COUGH?

COUGH has been reported as an adverse event in 980 FDA reports for DORNASE ALFA. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with DORNASE ALFA?

COUGH accounts for approximately 3.3% of all adverse event reports for DORNASE ALFA, making it a notable side effect.

What should I do if I experience COUGH while taking DORNASE ALFA?

If you experience cough while taking DORNASE ALFA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages